Nykredit A/S’s Elevance Health ELV Stock Holding History

Nykredit A/S’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32M	Buy	+82,705	New	+$30.7M	0.1%	169

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nykredit A/S's ELV Position: Q2 2026 in Review

Nykredit A/S opened a new position in Elevance Health (ELV) in Q2 2026: 82,705 shares worth $32M. The stake represents 0.1% of the portfolio and ranks #169 among its holdings.

1,286 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Nykredit A/S held 82,705 shares of Elevance Health worth $32M as of Q2 2026.
Elevance Health was a new Nykredit A/S position in Q2 2026.
Elevance Health made up 0.1% of Nykredit A/S's portfolio in Q2 2026, its #169 holding.
1,286 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.